Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories

about

Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories

Item

http://www.wikidata.org/entity/Q58701180

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Activity of Isavuconazole agai ...... ycology Reference Laboratories

@en

Activity of Isavuconazole agai ...... ycology Reference Laboratories

@nl

type

Item

label

Activity of Isavuconazole agai ...... ycology Reference Laboratories

@en

Activity of Isavuconazole agai ...... ycology Reference Laboratories

@nl

prefLabel

Activity of Isavuconazole agai ...... ycology Reference Laboratories

@en

Activity of Isavuconazole agai ...... ycology Reference Laboratories

@nl

P1476

Activity of Isavuconazole agai ...... ycology Reference Laboratories

@en

P2093

Carmita Sanders

http://www.w3.org/2001/XMLSchema#string

Connie Gibas

http://www.w3.org/2001/XMLSchema#string

Hongxin Fan

http://www.w3.org/2001/XMLSchema#string

James Mele

http://www.w3.org/2001/XMLSchema#string

Laura L Kovanda

http://www.w3.org/2001/XMLSchema#string

Paul R Rhomberg

http://www.w3.org/2001/XMLSchema#string

P2860

Role of isavuconazole in the treatment of invasive fungal infections

Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations

Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent

Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance

Clinical implications of globally emerging azole resistance in Aspergillus fumigatus.

Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data.

Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014

Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov.

P31

scholarly article

P356

10.1128/AAC.01230-18

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nathan P. Wiederhold

Michael A Pfaller

Mariana Castanheira

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30061288

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

infectious disease

P932

6153788

http://www.w3.org/2001/XMLSchema#string